NCT06810726 - Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

May 15, 2026

Study Completion Date

August 15, 2026

Conditions

Diabetic Foot UlcerType 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)Neuroischemic Foot UlcerChronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer)Chronic Wound Care

Interventions

DEVICE

Platelet Rich Plasma

Tropocells(R) Autologous Platelet-Rich Fibrin

Trial Locations (2)

78404

RECRUITING

WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus Christi

78414

RECRUITING

Woundcentrics Wound Care Center At Corpus Christi South, Corpus Christi